##gff-version 3
##sequence-region P08047 1 785
P08047	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:20068231,PMID:21406692	
P08047	UniProtKB	Chain	2	785	.	.	.	ID=PRO_0000047137;Note=Transcription factor Sp1	
P08047	UniProtKB	Zinc finger	626	650	.	.	.	Note=C2H2-type 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
P08047	UniProtKB	Zinc finger	656	680	.	.	.	Note=C2H2-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
P08047	UniProtKB	Zinc finger	686	708	.	.	.	Note=C2H2-type 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
P08047	UniProtKB	Region	2	82	.	.	.	Note=Repressor domain	
P08047	UniProtKB	Region	146	251	.	.	.	Note=Transactivation domain A (Gln-rich)	
P08047	UniProtKB	Region	261	495	.	.	.	Note=Transactivation domain B (Gln-rich)	
P08047	UniProtKB	Region	496	610	.	.	.	Note=Transactivation domain C (highly charged)	
P08047	UniProtKB	Region	619	785	.	.	.	Note=VZV IE62-binding	
P08047	UniProtKB	Region	708	785	.	.	.	Note=Domain D	
P08047	UniProtKB	Compositional bias	36	143	.	.	.	Note=Ser/Thr-rich	
P08047	UniProtKB	Compositional bias	271	379	.	.	.	Note=Ser/Thr-rich	
P08047	UniProtKB	Site	63	64	.	.	.	Note=Cleavage;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08047	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:20068231,PMID:21406692	
P08047	UniProtKB	Modified residue	2	2	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
P08047	UniProtKB	Modified residue	7	7	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:18239466;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163,PMID:18239466	
P08047	UniProtKB	Modified residue	59	59	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:17049555,ECO:0000269|PubMed:18199680,ECO:0000269|PubMed:18239466;Dbxref=PMID:16964243,PMID:23186163,PMID:17049555,PMID:18199680,PMID:18239466	
P08047	UniProtKB	Modified residue	101	101	.	.	.	Note=Phosphoserine%3B by ATM;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18171990,ECO:0000269|PubMed:18619531;Dbxref=PMID:18171990,PMID:18619531	
P08047	UniProtKB	Modified residue	278	278	.	.	.	Note=Phosphothreonine%3B by MAPK8;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:18199680;Dbxref=PMID:18199680	
P08047	UniProtKB	Modified residue	453	453	.	.	.	Note=Phosphothreonine%3B by MAPK1 and MAPK3;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11904305,ECO:0000269|PubMed:14593115,ECO:0000269|PubMed:16377629;Dbxref=PMID:11904305,PMID:14593115,PMID:16377629	
P08047	UniProtKB	Modified residue	612	612	.	.	.	Note=Phosphoserine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Modified residue	640	640	.	.	.	Note=Phosphothreonine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Modified residue	641	641	.	.	.	Note=Phosphoserine%3B by PKC/PRKCZ%3B alternate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16332679,ECO:0000269|PubMed:16943418;Dbxref=PMID:16332679,PMID:16943418	
P08047	UniProtKB	Modified residue	651	651	.	.	.	Note=Phosphothreonine%3B by PKC/PRKCZ;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P08047	UniProtKB	Modified residue	668	668	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18258854;Dbxref=PMID:18258854	
P08047	UniProtKB	Modified residue	670	670	.	.	.	Note=Phosphoserine%3B by PKC/PRKCZ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18258854;Dbxref=PMID:18258854	
P08047	UniProtKB	Modified residue	681	681	.	.	.	Note=Phosphothreonine%3B by PKC/PRKCZ;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17049555,ECO:0000269|PubMed:18258854;Dbxref=PMID:17049555,PMID:18258854	
P08047	UniProtKB	Modified residue	698	698	.	.	.	Note=Phosphoserine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Modified residue	702	702	.	.	.	Note=Phosphoserine%3B alternate;Ontology_term=ECO:0000269,ECO:0000305;evidence=ECO:0000269|PubMed:16332679,ECO:0000305|PubMed:20953893;Dbxref=PMID:16332679,PMID:20953893	
P08047	UniProtKB	Modified residue	703	703	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16478997;Dbxref=PMID:16478997	
P08047	UniProtKB	Modified residue	739	739	.	.	.	Note=Phosphothreonine%3B by MAPK1%2C MAPK3 and MAPK8;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11904305,ECO:0000269|PubMed:14593115,ECO:0000269|PubMed:16377629;Dbxref=PMID:11904305,PMID:14593115,PMID:16377629	
P08047	UniProtKB	Glycosylation	491	491	.	.	.	Note=O-linked (GlcNAc) serine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11371615,ECO:0000269|PubMed:9343410;Dbxref=PMID:11371615,PMID:9343410	
P08047	UniProtKB	Glycosylation	612	612	.	.	.	Note=O-linked (GlcNAc) serine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Glycosylation	640	640	.	.	.	Note=O-linked (GlcNAc) threonine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Glycosylation	641	641	.	.	.	Note=O-linked (GlcNAc) serine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Glycosylation	698	698	.	.	.	Note=O-linked (GlcNAc) serine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Glycosylation	702	702	.	.	.	Note=O-linked (GlcNAc) serine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16332679;Dbxref=PMID:16332679	
P08047	UniProtKB	Cross-link	16	16	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate	
P08047	UniProtKB	Cross-link	16	16	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
P08047	UniProtKB	Alternative sequence	1	7	.	.	.	ID=VSP_053934;Note=In isoform 2. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08047	UniProtKB	Alternative sequence	54	101	.	.	.	ID=VSP_053935;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:21798247;Dbxref=PMID:21798247	
P08047	UniProtKB	Natural variant	737	737	.	.	.	ID=VAR_019971;Note=T->A;Dbxref=dbSNP:rs3741665	
P08047	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Increase in protein stability. No change in sumoylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18239466;Dbxref=PMID:18239466	
P08047	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Enhanced transcriptional activity. V->R	
P08047	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Loss of sumoylation. No cleavage and reduced transcriptional activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16407261;Dbxref=PMID:16407261	
P08047	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Loss of sumoylation. Increased cleavage and enhanced transcriptional activity. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16407261;Dbxref=PMID:16407261	
P08047	UniProtKB	Mutagenesis	19	19	.	.	.	Note=No effect on sumoylation nor on proteolytic cleavage. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16407261;Dbxref=PMID:16407261	
P08047	UniProtKB	Mutagenesis	36	36	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	56	56	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss of phosphorylation. No effect on activated MAPK8-mediated phosphorylation. Similar loss of phosphorylation as by dephosphorylation by PP2AC. Reduced proteolytic processing. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17049555,ECO:0000269|PubMed:18199680,ECO:0000269|PubMed:18239466;Dbxref=PMID:17049555,PMID:18199680,PMID:18239466	
P08047	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Some association with chromatin%2C increased phosphorylation levels and decreased glycosylation. S->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17049555,ECO:0000269|PubMed:18199680,ECO:0000269|PubMed:18239466;Dbxref=PMID:17049555,PMID:18199680,PMID:18239466	
P08047	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Little effect on activated MAPK8-mediated phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18199680;Dbxref=PMID:18199680	
P08047	UniProtKB	Mutagenesis	81	81	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	85	85	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No effect on phosphorylation on DNA damage. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Significant reduction of phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18171990,ECO:0000269|PubMed:18619531;Dbxref=PMID:18171990,PMID:18619531	
P08047	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Increase in phosphorylation on DNA damage. S->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18171990,ECO:0000269|PubMed:18619531;Dbxref=PMID:18171990,PMID:18619531	
P08047	UniProtKB	Mutagenesis	117	117	.	.	.	Note=No effect on activated MAPK8-mediated phosphorylation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18199680;Dbxref=PMID:18199680	
P08047	UniProtKB	Mutagenesis	220	220	.	.	.	Note=No effect on dephosphorylation by PP2A. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17049555;Dbxref=PMID:17049555	
P08047	UniProtKB	Mutagenesis	250	250	.	.	.	Note=No effect on phosphorylation on DNA damage. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	278	278	.	.	.	Note=Almost complete abolition of activated MAPK8-mediated phosphorylation and 40%25 reduction in protein levels during mitosis. Protein levels reduced by 70%25 during mitosis%3B when associated with A-739. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18199680;Dbxref=PMID:18199680	
P08047	UniProtKB	Mutagenesis	278	278	.	.	.	Note=Increased protein stability during mitosis%3B when associated with D-739. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18199680;Dbxref=PMID:18199680	
P08047	UniProtKB	Mutagenesis	281	281	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	291	291	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	296	296	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	313	313	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	351	351	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	355	355	.	.	.	Note=No effect on dephosphorylation by PP2A. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11904305,ECO:0000269|PubMed:17049555;Dbxref=PMID:11904305,PMID:17049555	
P08047	UniProtKB	Mutagenesis	394	394	.	.	.	Note=No effect on phosphorylation on DNA damage. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	427	427	.	.	.	Note=No effect on phosphorylation on DNA damage. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	431	431	.	.	.	Note=No effect on phosphorylation on DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18619531;Dbxref=PMID:18619531	
P08047	UniProtKB	Mutagenesis	453	453	.	.	.	Note=Abolishes MAPK-mediated phosphorylation%2C 50%25 reduction in MAPK1/MAPK3-mediated activity on VEGF promoter and no effect on dephosphorylation by PP2A. Greatly reduced MAPK1-mediated activity on VEGF promoter%3B when associated with A-739. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11904305,ECO:0000269|PubMed:14593115,ECO:0000269|PubMed:17049555;Dbxref=PMID:11904305,PMID:14593115,PMID:17049555	
P08047	UniProtKB	Mutagenesis	491	491	.	.	.	Note=Loss of O-glycosylation. Increase in transcriptional activity. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11371615,ECO:0000269|PubMed:9343410;Dbxref=PMID:11371615,PMID:9343410	
P08047	UniProtKB	Mutagenesis	612	612	.	.	.	Note=Diminished glycosylation. Inhibits transcriptional activity%3B when associated with A-640%3B A-641%3B A-698 and A-702. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18513490;Dbxref=PMID:18513490	
P08047	UniProtKB	Mutagenesis	640	640	.	.	.	Note=Diminished glycosylation. Inhibits transcriptional activity%3B when associated with A-612%3B A-641%3B A-698 and A-702. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18513490;Dbxref=PMID:18513490	
P08047	UniProtKB	Mutagenesis	641	641	.	.	.	Note=Abolishes PRKCzeta-mediated phosphorylation. Diminished glycosylation. Inhibits transcriptional activity%3B when associated with A-612%3B A-640%3B A-641 and A-702. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16943418,ECO:0000269|PubMed:18513490;Dbxref=PMID:16943418,PMID:18513490	
P08047	UniProtKB	Mutagenesis	651	651	.	.	.	Note=No effect on dephosphorylation by PP2A. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17049555;Dbxref=PMID:17049555	
P08047	UniProtKB	Mutagenesis	668	668	.	.	.	Note=Abolishes PRKCzeta-mediated but not PKCdelta-mediated phosphorylation. No effect on DNA binding%3B when associated with A-670 and A-681. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18258854;Dbxref=PMID:18258854	
P08047	UniProtKB	Mutagenesis	670	670	.	.	.	Note=Abolishes PRKCzeta-mediated but not PKCdelta-mediated phosphorylation. No effect on DNA binding%3B when associated with A-668 and A-681. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18258854;Dbxref=PMID:18258854	
P08047	UniProtKB	Mutagenesis	681	681	.	.	.	Note=Abolishes PRKCzeta-mediated but not PKCdelta-mediated phosphorylation. Some effect on dephosphorylation by PP2A. No effect on DNA binding%3B when associated with A-668 and A-681. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17049555,ECO:0000269|PubMed:18258854;Dbxref=PMID:17049555,PMID:18258854	
P08047	UniProtKB	Mutagenesis	698	698	.	.	.	Note=Diminished glycosylation. Inhibits transcriptional activity%3B when associated with A-612%3B A-640%3B A-641 and A-702. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18513490;Dbxref=PMID:18513490	
P08047	UniProtKB	Mutagenesis	702	702	.	.	.	Note=Diminished glycosylation. Inhibits transcriptional activity%3B when associated with A-612%3B A-640%3B A-641 and A-698. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18513490;Dbxref=PMID:18513490	
P08047	UniProtKB	Mutagenesis	703	703	.	.	.	Note=Abolishes acetylation. Increases recruitment of p300 to the promoter and enhances gene transcription. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16478997;Dbxref=PMID:16478997	
P08047	UniProtKB	Mutagenesis	728	728	.	.	.	Note=Exhibits attenuated endoproteolytic cleavage%3B when associated with A-732. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18239466;Dbxref=PMID:18239466	
P08047	UniProtKB	Mutagenesis	732	732	.	.	.	Note=Exhibits attenuated endoproteolytic cleavage%3B when associated with A-728. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18239466;Dbxref=PMID:18239466	
P08047	UniProtKB	Mutagenesis	739	739	.	.	.	Note=Abolishes MAPK-mediated phosphorylation. 50%25 reduction in MAPK1/MAPK3-mediated activity on VEGF promoter%2C 40%25 reduction in protein levels during mitosis and no effect on dephosphorylation by PP2A. Greatly reduced MAPK1-mediated activity on VEGF promoter%3B when associated with A-453. Protein levels during mitosis reduced by 70%25%3B when associated with A-278. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11904305,ECO:0000269|PubMed:14593115,ECO:0000269|PubMed:17049555,ECO:0000269|PubMed:18199680;Dbxref=PMID:11904305,PMID:14593115,PMID:17049555,PMID:18199680	
P08047	UniProtKB	Mutagenesis	739	739	.	.	.	Note=Increased protein stability during mitosis%3B when associated with D-278. T->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11904305,ECO:0000269|PubMed:14593115,ECO:0000269|PubMed:17049555,ECO:0000269|PubMed:18199680;Dbxref=PMID:11904305,PMID:14593115,PMID:17049555,PMID:18199680	
P08047	UniProtKB	Sequence conflict	366	366	.	.	.	Note=D->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08047	UniProtKB	Sequence conflict	670	670	.	.	.	Note=S->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08047	UniProtKB	Beta strand	620	622	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1VA1	
P08047	UniProtKB	Beta strand	636	638	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1VA1	
P08047	UniProtKB	Helix	640	651	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1VA1	
P08047	UniProtKB	Turn	661	663	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1VA2	
P08047	UniProtKB	Beta strand	666	668	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1VA2	
P08047	UniProtKB	Helix	670	677	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1SP2	
P08047	UniProtKB	Turn	678	680	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1SP2	
P08047	UniProtKB	Turn	689	692	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1SP1	
P08047	UniProtKB	Helix	699	706	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1SP1	
P08047	UniProtKB	Helix	707	709	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1SP1	
